Abstract:BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles.METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei (CHCN-BTH) using a stratified, multistage cluster sampling method. Data were collected through questionnaire surveys, anthropometric measures and laboratory tests. Restricted cubic spline (RCS) functions, multivariate logistic regression, sensitivity analyses and stratified analyses were used to evaluate the association between Lp(a) and CHD.RESULTS: A total of 25,343 participants were included, with 1,364 (5.38%) identified as having CHD. Elevated Lp(a) levels were linearly related to an increased risk of CHD (P<sub>overall-association</sub><0.0001 and P<sub>nonlinear-association</sub>=0.8468). Multivariate logistic regression analysis indicated that subjects with Lp(a) ≥300 mg/L had a higher risk of CHD [OR (95% CI): 1.36 (1.17, 1.57)] than did individuals with Lp(a) <300 mg/L. Compared with individuals with Lp(a) <119.0 mg/L (<50th percentile), the ORs (95% CI) for CHD in the 51st-80th, 81st-95th and >95th percentiles were 1.07 (0.93, 1.23), 1.26 (1.07, 1.50) and 1.68 (1.30, 2.17), respectively (P for trend <0.0001). This association was also found among the subgroup of subjects without dyslipidemia, including those with normal total cholesterol (TC) (<6.2 mmol/L), triglycerides (TG) (<2.3 mmol/L), high-density lipoprotein cholesterol (HDL-C) (≥1.0 mmol/L) and low-density lipoprotein cholesterol (LDL-C) (<4.1 mmol/L). Elevated Lp(a) and dyslipidemia significantly contributed to a higher risk of CHD with synergistic effects. Stratified analyses showed that elevated Lp(a) concentrations were significantly associated with an increased risk of CHD in the subgroups of individuals who were noncurrent drinkers, overweight individuals, individuals with hypertension, individuals who engaged in moderate physical activity, those without diabetes mellitus and individuals in Beijing and Tianjin.CONCLUSIONS: Elevated Lp(a) concentrations were linearly associated with a higher risk of CHD in the general Chinese community population, especially in normolipidemic subjects. Both dyslipidemia and elevated Lp(a) independently or synergistically contributed to the risk of CHD. Our results suggest that more attention should be paid to the levels of Lp(a) in normolipidemic subjects, which may be an early predictor of CHD.

Impact of Lipoprotein(a) Level on Cardiometabolic Disease in the Chinese Population: the CHCN-BTH Study

Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study

Lipoprotein(a) and Cardiovascular Disease in Chinese Population

Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population

Correlation Between Small and Dense Low‐density Lipoprotein Cholesterol and Cardiovascular Events in Beijing Community Population

Exploring the role of lipoprotein(a) in cardiovascular diseases and diabetes in Chinese population

Association of Lipoprotein (a) Variants with Risk of Cardiovascular Disease: a Mendelian Randomization Study

Elevated Plasma Lipoprotein(a) Levels Were Associated with Increased Risk of Cardiovascular Events in Chinese Patients with Stable Coronary Artery Disease

Serum Lipoprotein(A) Positively Correlates With Coronary Artery Calcification In Low-Risk Chinese Han Patients: A Study From A Single Center

[Distribution and Influencing Factors of Lipoprotein (a) Levels in Non-Arteriosclerotic Cardiovascular Disease Population in China].

Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China

Lp(a) and high-sensitivity C-reactive protein are predictive biomarkers for coronary heart disease in Chinese patients with type 2 diabetes mellitus

A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population

Study on the Relationship Between Hormone and Lp(a) in Chinese Overweight/obese Patients

Association Between Lipoprotein (a) Levels and Metabolic Syndrome in a Middle-aged and Elderly Chinese Cohort.

Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses

Long-Term Coronary Heart Disease Risk Associated With Very-Low-Density Lipoprotein Cholesterol In Chinese: The Results Of A 15-Year Chinese Multi-Provincial Cohort Study (Cmcs)

Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population.

Lipoprotein(a) is Associated with Left Ventricular Systolic Dysfunction in a Chinese Population of Patients with Hypertension and Without Coronary Artery Disease.

Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes

Comparison of lipoprotein derived indices for evaluating cardio-metabolic risk factors and subclinical organ damage in middle-aged Chinese adults